2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)

Show full item record



Permalink

http://hdl.handle.net/10138/232152

Citation

Catapano , A L , Graham , I , De Backer , G , Wiklund , O , Chapman , M J , Drexel , H , Hoes , A W , Jennings , C S , Landmesser , U , Pedersen , T R , Reiner , Z , Riccardi , G , Taskinen , M-R , Tokgozoglu , L , Verschuren , W M M , Vlachopoulos , C , Wood , D A & Luis Zamorano , J 2016 , ' 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR) ' , Atherosclerosis , vol. 253 , pp. 281-344 . https://doi.org/10.1016/j.atherosclerosis.2016.08.018

Title: 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)
Author: Catapano, Alberico L.; Graham, Ian; De Backer, Guy; Wiklund, Olov; Chapman, M. John; Drexel, Heinz; Hoes, Arno W.; Jennings, Catriona S.; Landmesser, Ulf; Pedersen, Terje R.; Reiner, Zeljko; Riccardi, Gabriele; Taskinen, Marja-Riita; Tokgozoglu, Lale; Verschuren, W. M. Monique; Vlachopoulos, Charalambos; Wood, David A.; Luis Zamorano, Jose
Other contributor: University of Helsinki, Research Programs Unit




Date: 2016-10
Language: eng
Number of pages: 64
Belongs to series: Atherosclerosis
ISSN: 0021-9150
DOI: https://doi.org/10.1016/j.atherosclerosis.2016.08.018
URI: http://hdl.handle.net/10138/232152
Subject: dyslipidaemias
cholesterol
triglycerides
low-density lipoproteins
high-density lipoproteins
apolipoprotein B
lipoprotein remnants
total cardiovascular risk
treatment, lifestyle
treatment, drugs
treatment, adherence
CORONARY-HEART-DISEASE
DENSITY-LIPOPROTEIN CHOLESTEROL
RANDOMIZED CONTROLLED-TRIALS
HIGH-DOSE ATORVASTATIN
TYPE-2 DIABETES-MELLITUS
LIPID-LOWERING THERAPY
CHRONIC KIDNEY-DISEASE
POPULATION-BASED COHORT
APOLIPOPROTEIN C-III
ALL-CAUSE MORTALITY
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0021915016312679_main.pdf 11.86Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record